Index of reports
> Cases with Sopor (26)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Depakene (Valproic Acid) where reactions include sopor. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Depakene side effects in male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-18
Patient: male
Reactions: Hypotension, Hypoglycaemia, Bradykinesia, Sopor, Bradyphrenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Lyrica
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Tramadol HCL
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Apidra
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Humalog
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Duloxetine Hydrochloride
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Depakene
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Valium
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Other drugs received by patient: Ramipril
Possible Depakene side effects in female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-18
Patient: female
Reactions: Intentional Overdose, Sopor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depakene
Administration route: Oral
Indication: Borderline Personality Disorder
Depakene
Administration route: Oral
Indication: Intentional Overdose
Start date: 2012-07-06
End date: 2012-07-06
Zolpidem Tartrate
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-06
End date: 2012-07-06
Abilify
Administration route: Oral
Indication: Borderline Personality Disorder
Abilify
Administration route: Oral
Indication: Intentional Overdose
Start date: 2012-07-06
End date: 2012-07-06
Possible Depakene side effects in female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-18
Patient: female
Reactions: Intentional Overdose, Sopor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Abilify
Administration route: Oral
Indication: Intentional Overdose
Start date: 2012-07-06
End date: 2012-07-06
Abilify
Administration route: Oral
Indication: Borderline Personality Disorder
Depakene
Administration route: Oral
Indication: Intentional Overdose
Start date: 2012-07-06
End date: 2012-07-06
Depakene
Administration route: Oral
Indication: Borderline Personality Disorder
Zolpidem Tartrate
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-06
End date: 2012-07-06
Possible Depakene side effects in male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-09
Patient: male
Reactions: Hypokinesia, Intentional Overdose, Hypoglycaemia, Hypotension, Suicide Attempt, Sopor
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Humalog
Dosage: once
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Valium
Dosage: once
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Lyrica
Dosage: once
Administration route: Oral
Indication: Diabetic Neuropathy
Start date: 2012-05-23
End date: 2012-05-23
Apidra
Dosage: 100 iu/milliltre, 3 milliliters once
Indication: Type 1 Diabetes Mellitus
Start date: 2012-05-23
End date: 2012-05-23
Duloxetime Hydrochloride
Indication: Suicide Attempt
Optiset
Dosage: 3 times a day, once
Indication: Device Therapy
Start date: 2012-05-23
End date: 2012-05-23
Duloxetime Hydrochloride
Dosage: once
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-23
End date: 2012-05-23
Depakene
Dosage: once
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Tramadol HCL
Dosage: once
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Lyrica
Indication: Suicide Attempt
Apidra
Indication: Suicide Attempt
Other drugs received by patient: Ramipril; Lantus
Possible Depakene side effects in 40 year old male
Reported by a physician from Italy on 2012-07-06
Patient: 40 year old male
Reactions: Hypokinesia, Intentional Overdose, Hypoglycaemia, Hypotension, Suicide Attempt, Sopor
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Lyrica
Dosage: dose:14 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Duloxetine Hydrochloride
Dosage: dose:56 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Valium
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Apidra Optiset
Start date: 2012-05-23
End date: 2012-05-23
Depakene
Dosage: dose:60 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Duloxetine Hydrochloride
Administration route: Oral
Duloxetine Hydrochloride
Dosage: dose:56 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Apidra Optiset
Dosage: dose reported as 18iu, 26iu and 26iu
Optiset
Indication: Device Therapy
Apidra Optiset
Start date: 2012-05-23
End date: 2012-05-23
Humalog
Start date: 2012-05-23
End date: 2012-05-23
Tramadol HCL
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Lyrica
Administration route: Oral
Apidra Optiset
Dosage: dose reported as 18iu, 26iu and 26iu
Optiset
Start date: 2012-05-23
End date: 2012-05-23
Duloxetine Hydrochloride
Administration route: Oral
Lyrica
Dosage: dose:14 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Lyrica
Administration route: Oral
Indication: Diabetic Neuropathy
Other drugs received by patient: Ramipril; Lantus
Possible Depakene side effects in male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-18
Patient: male
Reactions: Hypokinesia, Intentional Overdose, Hypoglycaemia, Hypotension, Suicide Attempt, Sopor
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Apidra
Dosage: once
Indication: Type 1 Diabetes Mellitus
Start date: 2012-05-23
End date: 2012-05-23
Lyrica
Dosage: once
Administration route: Oral
Indication: Diabetic Neuropathy
Start date: 2012-05-23
End date: 2012-05-23
Apidra
Indication: Suicide Attempt
Duloxetime Hydrochloride
Dosage: once
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-23
End date: 2012-05-23
Tramadol HCL
Dosage: once
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Valium
Dosage: once
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Duloxetime Hydrochloride
Indication: Suicide Attempt
Depakene
Dosage: once
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Humalog
Dosage: once
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Optiset
Dosage: 3 in 1 day, once
Indication: Device Therapy
Start date: 2012-05-23
End date: 2012-05-23
Lyrica
Indication: Suicide Attempt
Other drugs received by patient: Ramipril; Lantus
Possible Depakene side effects in 40 year old male
Reported by a physician from Italy on 2012-06-15
Patient: 40 year old male
Reactions: Hypokinesia, Intentional Overdose, Hypoglycaemia, Hypotension, Suicide Attempt, Sopor
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Duloxetine Hydrochloride
Administration route: Oral
Duloxetine Hydrochloride
Dosage: dose:56 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Tramadol HCL
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Lyrica
Dosage: dose:14 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Apidra Optiset
Dosage: dose reported as 18iu, 26iu and 26iu
Apidra Optiset
Dosage: dose reported as 18iu, 26iu and 26iu
Apidra Optiset
Start date: 2012-05-23
End date: 2012-05-23
Optiset
Indication: Device Therapy
Duloxetine Hydrochloride
Administration route: Oral
Lyrica
Administration route: Oral
Depakene
Dosage: dose:60 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Duloxetine Hydrochloride
Dosage: dose:56 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Valium
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Apidra Optiset
Start date: 2012-05-23
End date: 2012-05-23
Optiset
Start date: 2012-05-23
End date: 2012-05-23
Lyrica
Dosage: dose:14 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Humalog
Start date: 2012-05-23
End date: 2012-05-23
Lyrica
Administration route: Oral
Indication: Diabetic Neuropathy
Other drugs received by patient: Ramipril; Lantus
Possible Depakene side effects in male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-15
Patient: male
Reactions: Hypokinesia, Intentional Overdose, Hypotension, Hypoglycaemia, Suicide Attempt, Sopor
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Apidra
Dosage: once
Indication: Type 1 Diabetes Mellitus
Start date: 2012-05-23
End date: 2012-05-23
Humalog
Dosage: once
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Apidra
Indication: Suicide Attempt
Duloxetime Hydrochloride
Dosage: once
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-23
End date: 2012-05-23
Depakene
Dosage: once
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Duloxetime Hydrochloride
Indication: Suicide Attempt
Lyrica
Dosage: once
Administration route: Oral
Indication: Diabetic Neuropathy
Start date: 2012-05-23
End date: 2012-05-23
Tramadol HCL
Dosage: once
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Lyrica
Indication: Suicide Attempt
Optiset
Dosage: 3 in 1 day, once
Indication: Device Therapy
Start date: 2012-05-23
End date: 2012-05-23
Valium
Dosage: once
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-05-23
End date: 2012-05-23
Other drugs received by patient: Ramipril
Possible Depakene side effects in 40 year old male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-13
Patient: 40 year old male
Reactions: Hypokinesia, Intentional Overdose, Hypoglycaemia, Hypotension, Suicide Attempt, Sopor
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Humalog
Start date: 2012-05-23
End date: 2012-05-23
Duloxetine Hydrochloride
Dosage: dose:56 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Duloxetine Hydrochloride
Dosage: dose:56 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Valium
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Lyrica
Dosage: dose:14 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Apidra Optiset
Dosage: dose reported as 18iu, 26iu and 26iu
Apidra Optiset
Dosage: dose reported as 18iu, 26iu and 26iu
Duloxetine Hydrochloride
Administration route: Oral
Lyrica
Dosage: dose:14 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Tramadol HCL
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Apidra Optiset
Start date: 2012-05-23
End date: 2012-05-23
Optiset
Indication: Device Therapy
Optiset
Start date: 2012-05-23
End date: 2012-05-23
Depakene
Dosage: dose:60 unit(s)
Administration route: Oral
Start date: 2012-05-23
End date: 2012-05-23
Duloxetine Hydrochloride
Administration route: Oral
Lyrica
Administration route: Oral
Indication: Diabetic Neuropathy
Lyrica
Administration route: Oral
Apidra Optiset
Start date: 2012-05-23
End date: 2012-05-23
Other drugs received by patient: Ramipril
Possible Depakene side effects in 46 year old female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-05-03
Patient: 46 year old female, weighing 60.0 kg (132.0 pounds)
Reactions: Confusional State, Multiple Drug Overdose Intentional, Self Injurious Behaviour, Sopor
Drug(s) suspected as cause:
Alprazolam
Administration route: Oral
Indication: Multiple Drug Overdose Intentional
Start date: 2012-04-21
End date: 2012-04-21
Fluvoxamine Maleate
Administration route: Oral
Indication: Multiple Drug Overdose Intentional
Start date: 2012-04-21
End date: 2012-04-21
Topamax
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-21
End date: 2012-04-21
Risperidone
Administration route: Oral
Indication: Multiple Drug Overdose Intentional
Start date: 2012-04-21
End date: 2012-04-21
Depakene
Administration route: Oral
Indication: Multiple Drug Overdose Intentional
Start date: 2012-04-21
End date: 2012-04-21
Possible Depakene side effects in 42 year old male
Reported by a physician from Italy on 2012-04-23
Patient: 42 year old male
Reactions: Multiple Drug Overdose Intentional, Self Injurious Behaviour, Sopor
Drug(s) suspected as cause:
Voltaren
Administration route: Oral
Indication: Self Injurious Behaviour
Start date: 2012-04-15
End date: 2012-04-15
Ramipril
Administration route: Oral
Indication: Self Injurious Behaviour
Start date: 2012-04-15
End date: 2012-04-15
Venlafaxine
Administration route: Oral
Indication: Self Injurious Behaviour
Start date: 2012-04-15
End date: 2012-04-15
Aspirin
Administration route: Oral
Indication: Self Injurious Behaviour
Start date: 2012-04-15
End date: 2012-04-15
Losartan Potassium
Administration route: Oral
Indication: Self Injurious Behaviour
Start date: 2012-04-15
End date: 2012-04-15
Alcohol
Administration route: Oral
Indication: Self Injurious Behaviour
Start date: 2012-04-15
End date: 2012-04-15
Mirtazapine
Administration route: Oral
Indication: Self Injurious Behaviour
Start date: 2012-04-15
End date: 2012-04-15
Invega
Administration route: Oral
Start date: 2012-04-15
End date: 2012-04-15
Invega
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Norvasc
Administration route: Oral
Indication: Self Injurious Behaviour
Start date: 2012-04-15
End date: 2012-04-15
Depakene
Administration route: Oral
Indication: Self Injurious Behaviour
Start date: 2012-04-15
End date: 2012-04-15
Possible Depakene side effects in male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-04-09
Patient: male
Reactions: Hypotension, Multiple Drug Overdose Intentional, Sopor, Sinus Bradycardia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: gastro-resistant tablet, 1 in 1 d
Administration route: Oral
Indication: Borderline Personality Disorder
Zyprexa
Dosage: coated, once
Administration route: Oral
Start date: 2011-01-30
End date: 2011-01-30
Depakene
Dosage: once, gastro-resistant tablet
Administration route: Oral
Start date: 2012-01-30
End date: 2012-01-30
Zyprexa
Dosage: coated
Administration route: Oral
Indication: Borderline Personality Disorder
Lorazepam
Dosage: once
Administration route: Oral
Indication: Intentional Overdose
Start date: 2012-01-30
End date: 2012-01-30
Other drugs received by patient: Diazepam
Possible Depakene side effects in female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-03-29
Patient: female
Reactions: Intentional Overdose, Sopor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depakene
Other drugs received by patient: Amisulpride; Zolpidem; Fluphenazine HCL; ALL Other Therapeutic Products; EN
Possible Depakene side effects in female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-03-16
Patient: female
Reactions: Intentional Overdose, Sopor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depakene
Other drugs received by patient: EN; Amisulpride; Fluphenazine HCL; ALL Other Therapeutic Products; Zolpidem
Possible Depakene side effects in 81 year old male
Reported by a health professional (non-physician/pharmacist) from Austria on 2012-02-17
Patient: 81 year old male
Reactions: Dysphoria, Agitation, Sopor, Somnolence, Delirium
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Seroquel
Dosage: 100 mg daily
Administration route: Oral
Start date: 2011-10-31
End date: 2011-11-03
Lamictal
Dosage: 300 mg daily
Indication: Product Used FOR Unknown Indication
Start date: 2009-01-01
End date: 2011-11-05
Seroquel
Dosage: 50 mg daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-01-01
End date: 2011-10-31
Seroquel
Dosage: 300 mg daily
Administration route: Oral
Start date: 2011-11-04
End date: 2011-11-07
Seroquel
Dosage: 150 mg daily
Administration route: Oral
Start date: 2011-10-31
End date: 2011-11-03
Seroquel
Dosage: 500 mg daily
Administration route: Oral
Start date: 2011-11-03
End date: 2011-11-04
Lamictal
Dosage: 100 mg daily
Administration route: Oral
Start date: 2011-11-05
End date: 2011-11-07
Lorazepam
Dosage: 3.75 mg daily
Start date: 2011-11-07
End date: 2011-11-30
Lithium Carbonate
Dosage: daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-01-01
End date: 2011-11-07
Lorazepam
Dosage: 4 mg daily
Indication: Product Used FOR Unknown Indication
Start date: 2011-11-03
End date: 2011-11-07
Depakene
Dosage: 800 mg daily
Indication: Product Used FOR Unknown Indication
Start date: 2011-11-02
End date: 2011-11-04
Spironolactone
Dosage: 25 mg daily
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-31
End date: 2011-11-06
Other drugs received by patient: Digitoxin TAB; Marcoumar
Possible Depakene side effects in 21 year old female
Reported by a physician from Italy on 2012-02-15
Patient: 21 year old female
Reactions: Multiple Drug Overdose, Sopor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Fluoxetine
Dosage: total: 360mg
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-01-09
End date: 2012-01-09
Depakene
Dosage: total: 4gm
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-01-09
End date: 2012-01-09
Possible Depakene side effects in 21 year old female
Reported by a physician from Italy on 2012-02-08
Patient: 21 year old female
Reactions: Intentional Self-Injury, Sopor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: total: 4gm
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-01-09
End date: 2012-01-09
Fluoxetine
Dosage: total: 360mg
Administration route: Oral
Indication: Suicide Attempt
Start date: 2012-01-09
End date: 2012-01-09
Possible Depakene side effects in 44 year old female
Reported by a physician from Italy on 2011-12-06
Patient: 44 year old female
Reactions: Vomiting, Multiple Drug Overdose Intentional, Sinus Tachycardia, Sopor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Diazepam
Dosage: .5 percent, 40 drops total
Administration route: Oral
Indication: Intentional Overdose
Start date: 2011-09-13
End date: 2011-09-13
Diazepam
Indication: Anxiety
Depakene
Dosage: 20 unit (500 mg tablet) total
Administration route: Oral
Indication: Intentional Overdose
Start date: 2011-09-13
End date: 2011-09-13
Depakene
Indication: Schizoaffective Disorder
Nozinan
Dosage: 20 unit (25 mg tablet)
Administration route: Oral
Indication: Intentional Overdose
Start date: 2011-09-13
End date: 2011-09-13
Other drugs received by patient: Depakene; Alcohol
Possible Depakene side effects in 44 year old female
Reported by a physician from Italy on 2011-11-23
Patient: 44 year old female
Reactions: Vomiting, Multiple Drug Overdose Intentional, Sopor, Sinus Tachycardia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Nozinan
Dosage: 20 unit (25 mg tablet)
Administration route: Oral
Indication: Intentional Overdose
Start date: 2011-09-13
End date: 2011-09-13
Diazepam
Indication: Anxiety
Depakene
Dosage: 20 unit (500 mg tablet) total
Administration route: Oral
Indication: Intentional Overdose
Start date: 2011-09-13
End date: 2011-09-13
Depakene
Indication: Schizoaffective Disorder
Diazepam
Dosage: .5 percent, 40 drops total
Administration route: Oral
Indication: Intentional Overdose
Start date: 2011-09-13
End date: 2011-09-13
Other drugs received by patient: Depakene; Alcohol
Possible Depakene side effects in male
Reported by a physician from Italy on 2011-11-14
Patient: male
Reactions: Multiple Drug Overdose Intentional, Sopor, Bradyphrenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Seroquel
Administration route: Oral
Start date: 2011-06-21
End date: 2011-06-21
Diazepam
Administration route: Oral
Start date: 2011-06-21
End date: 2011-06-21
Lendormin
Administration route: Oral
Indication: Depression
Start date: 2011-06-21
End date: 2011-06-21
Depakene
Administration route: Oral
Indication: Personality Disorder
Start date: 2011-06-21
End date: 2011-06-21
Depakene
Administration route: Oral
Start date: 2011-06-06
End date: 2011-06-21
Lendormin
Administration route: Oral
Start date: 2011-06-06
End date: 2011-06-21
Other drugs received by patient: Zoloft; Omeprazole; Lasix
Possible Depakene side effects in male
Reported by a physician from Italy on 2011-11-04
Patient: male
Reactions: Multiple Drug Overdose Intentional, Bradyphrenia, Sopor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lendormin
Administration route: Oral
Start date: 2011-06-21
End date: 2011-06-21
Seroquel
Administration route: Oral
Start date: 2011-06-21
End date: 2011-06-21
Depakene
Administration route: Oral
Start date: 2011-06-21
End date: 2011-06-21
Diazepam
Dosage: 0.5% drops oral solution 20 ml vial, used 200 mg once/single administration
Administration route: Oral
Start date: 2011-06-21
End date: 2011-06-21
Possible Depakene side effects in 22 year old male
Reported by a physician from Croatia (Local Name: Hrvatska) on 2011-11-03
Patient: 22 year old male
Reactions: Intentional Overdose, Axillary Nerve Injury, Sopor, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depakene
Other drugs received by patient: Zoloft
Possible Depakene side effects in 22 year old male
Reported by a physician from Croatia (Local Name: Hrvatska) on 2011-10-28
Patient: 22 year old male
Reactions: Intentional Overdose, Axillary Nerve Injury, Asthenia, Sopor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depakene
Other drugs received by patient: Zoloft
Possible Depakene side effects in 24 year old female
Reported by a pharmacist from Italy on 2011-10-19
Patient: 24 year old female
Reactions: Intentional Overdose, Suicide Attempt, Sopor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: 15 grams total
Administration route: Oral
Indication: Suicide Attempt
Start date: 2011-06-23
End date: 2011-06-23
Acetaminophen
Dosage: 5 mg total
Administration route: Oral
Indication: Intentional Self-Injury
Start date: 2011-06-23
End date: 2011-06-23
Possible Depakene side effects in 24 year old female
Reported by a pharmacist from Italy on 2011-10-09
Patient: 24 year old female
Reactions: Intentional Overdose, Suicide Attempt, Sopor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Acetaminophen
Dosage: 5 mg total
Administration route: Oral
Indication: Intentional Self-Injury
Start date: 2011-06-23
End date: 2011-06-23
Depakene
Dosage: 15 grams total
Administration route: Oral
Indication: Suicide Attempt
Start date: 2011-06-23
End date: 2011-06-23
Possible Depakene side effects in male
Reported by a physician from Italy on 2011-10-05
Patient: male
Reactions: Overdose, Heart Rate Decreased, Intentional Overdose, Bradycardia, Intentional Self-Injury, Sopor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
EN
Indication: Intentional Self-Injury
EN
Dosage: 20ml total, (prescribed 40 drops daily)
Administration route: Oral
Indication: Personality Disorder
Start date: 2011-08-23
End date: 2011-08-23
Depakene
Dosage: 45 units total (prescribed 500mg 1 unit qd)
Administration route: Oral
Indication: Personality Disorder
Start date: 2011-08-23
End date: 2011-08-23
Depakene
Indication: Intentional Self-Injury
|